hodgkin disease
Showing NaN - NaN of 10
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +2 more
-
Birmingham, Alabama
- +77 more
Jul 21, 2022
Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +3 more
-
Los Angeles, California
- +37 more
Oct 25, 2021
Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -
Completed
- Hodgkin Disease
- +3 more
- LMP1/2 CTLs (ALCI - Group A)
- +8 more
-
Houston, Texas
- +1 more
May 26, 2020
Hodgkin Disease Trial in Houston (Filgrastim SD/01, Adriamycin, Bleomycin)
Completed
- Hodgkin Disease
- Filgrastim SD/01
- +4 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 30, 2018
Hodgkin Disease, Non-Hodgkins Lymphoma Trial in Houston (Infusion of EBV Specific Cytotoxic T-Lymphocytes)
Terminated
- Hodgkin Disease
- Non-Hodgkins Lymphoma
- Infusion of EBV Specific Cytotoxic T-Lymphocytes
-
Houston, Texas
- +1 more
Nov 5, 2012
Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))
Completed
- Hodgkin Disease
- +4 more
- SGN-30 (monoclonal antibody)
-
Birmingham, Alabama
- +9 more
Oct 7, 2011
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma Trial in United States (Leuprolide acetate depot (LAD) 11.25 mg 3
Terminated
- Hodgkin Disease
- +3 more
- Leuprolide acetate depot (LAD) 11.25 mg 3 Month
- Matched placebo
-
Saint Louis, Missouri
- +3 more
Apr 9, 2010